Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Pharmacogenetics and Pharmacokinetics of Posaconazole in Patients with Acute Myeloid Leukemia: Useful Tools for Antifungal Stewardship

Silvia Corcione, Cecilia Grosso, Ernesta Audisio, Jessica Cusato, Miriam Antonucci, Alessandro Busca, Benedetto Bruno, Annamaria Gulla, Antonio d'Avolio, francesco Giuseppe de Rosa

Blood (2023) 142 (Supplement 1): 5849.

https://doi.org/10.1182/blood-2023-190034

Published: 2023

Journal Articles

Impact of COVID-19 in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax: A Possible Role of the Association to Anti-CD20 Antibody? a Multicentre Seifem Study

Blood (2023) 142 (Supplement 1): 3283.

https://doi.org/10.1182/blood-2023-180955

Published: 2023

Journal Articles

Prognostic Factors Impacting Post-Transplant Outcomes in Adult T-Cell Acute Lymphoblastic Leukemia: A Registry-Based Study By the EBMT Acute Leukemia Working Party

Blood (2023) 142 (Supplement 1): 2237.

https://doi.org/10.1182/blood-2023-180686

Published: 2023

Journal Articles

Chronic Obstructive Pulmonary Disease and Previous Infections Have Impact on Infectious Complications in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax: A Multicentre Seifem Study

Blood (2023) 142 (Supplement 1): 6529.

https://doi.org/10.1182/blood-2023-181037

Published: 2023

Journal Articles

Score to Guide Donor Choice in Haploidentical Stem Cell Transplant Using Post-Transplant Cyclophosphamide for Patients with Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the EBMT

Blood (2023) 142 (Supplement 1): 4932.

https://doi.org/10.1182/blood-2023-180075

Published: 2023

Journal Articles

Gimema Seifem Real-Life Study VS Randomized CPX-351 Registrative Trial for Older Patients with Secondary ACUTE Myeloid Leukemia: An Unanchored Matching-Adjusted Indirect Comparison of Infection Rates and Survival Outcomes

Blood (2023) 142 (Supplement 1): 5845.

https://doi.org/10.1182/blood-2023-189358

Published: 2023

Journal Articles

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Ola Blennow, Maria Gomes da Silva, Andreas Glenthøj, Jaap van Doesum, Yavuz M. Bilgin, Alberto López-García, Federico Itri, Raquel Nunes Rodrigues, Barbora Weinbergerová, Francesca Farina, Giulia Dragonetti, Caroline Berg Venemyr, Jens van Praet, Ozren Jaksic, Toni Valković, Iker Falces-Romero, Sonia Martín-Pérez, Moraima Jiménez, Julio Dávila-Valls, Martin Schönlein, Emanuele Ammatuna, Stef Meers, Mario Delia, Zlate Stojanoski, Anna Nordlander, Tobias Lahmer, László Imre Pinczés, Caterina Buquicchio, Klára Piukovics, Irati Ormazabal-Vélez, Nicola Fracchiolla, Michail Samarkos, Gustavo-Adolfo Méndez, José-Ángel Hernández-Rivas, Ildefonso Espigado, Martin Cernan, Verena Petzer, Sylvain Lamure, Roberta di Blasi, Joyce Marques de Almedia, Michelina Dargenio, Monika M. Biernat, Mariarita Sciumè, Cristina de Ramón, Nick de Jonge, Josip Batinić, Avinash Aujayeb, Monia Marchetti, Guillemette Fouquet, Noemí Fernández, Giovanni Zambrotta, Maria Vittoria Sacchi, Anna Guidetti, Fatih Demirkan, Lucia Prezioso, Zdeněk Ráčil, Marcio Nucci, Miloš Mladenović, Raphaël Liévin, Michaela Hanáková, Stefanie Gräfe, Uluhan Sili, Marina Machado, Chiara Cattaneo, Tatjana Adžić-Vukičević, Luisa Verga, Jorge Labrador, Laman Rahimli, Matteo Bonanni, Francesco Passamonti, Antonio Pagliuca, Paolo Corradini, Martin Hoenigl, Philipp Koehler, Alessandro Busca, Oliver A. Cornely

Blood (2022) 140 (26): 2773–2787.

https://doi.org/10.1182/blood.2022017257

Published: 2022

Includes: Supplemental data

Journal Articles

Long-Term Analysis of an Open-Label, Multicentre, Randomized Phase 3 Trial Comparing Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine As a Preparative Regimen for Allogeneic Stem-Cell Transplantation in Patients with Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 7667–7669.

https://doi.org/10.1182/blood-2022-162472

Published: 2022

Journal Articles

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

Blood (2022) 139 (10): 1588–1592.

https://doi.org/10.1182/blood.2021014124

Published: 2022

Includes: Supplemental data

Journal Articles

Comparative Study of Treosulfan Plus Fludarabine (FT14) with Busulfan Plus Fludarabine (FB4) for Acute Myeloid Leukemia in First or Second Complete Remission: An Analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)

Blood (2021) 138 (Supplement 1): 1787.

https://doi.org/10.1182/blood-2021-146303

Published: 2021

Journal Articles

Significance of Degree of HLA Disparity When Using Haploidentical Donors with T-Replete PBSC and Post-Transplantation Cyclophosphamide (PTCy) in Acute Myeloid Leukemia (AML) in First Complete Hematologic Remission (CR1)

Mohamed A. Kharfan-Dabaja, Myriam Labopin, Ernesto Ayala, Ali Bazarbachi, Didier Blaise, Yener Koc, Jan Vydra, Alessandro Busca, Luca Castagna, Yana Novis, Andrew McDonald, Claude-Eric Bulabois, Christoph Schmid, Concepcion Herrera Arroyo, Edouard Forcade, Fabio Ciceri, Jaime Sanz, Arnon Nagler, Mohamad Mohty

Blood (2021) 138 (Supplement 1): 3910.

https://doi.org/10.1182/blood-2021-149651

Published: 2021

Journal Articles

Posaconazole at Standard Dose Is Safe and More Effective Than Echinocandins As IFD Prophylaxis in Patients with FLT3 Mutated AML Treated with Midostaurin

Chiara Cattaneo, Francesco Marchesi, Valentina Bonuomo, Nicola S Fracchiolla, Anna Candoni, Marianna Criscuolo, Lucia Prezioso, Crescenza Pasciolla, Maria Ilaria Del Principe, Michelina Dargenio, Giuseppe Tarantini, Maria Enza Mitra, Francesca Farina, Federica Colnaghi, Mariarita Sciumè, Gianpaolo Nadali, Alessandro Busca, Giuseppe Rossi, Livio Pagano

Blood (2021) 138 (Supplement 1): 4381.

https://doi.org/10.1182/blood-2021-149080

Published: 2021

Journal Articles

Letermovir Prophylaxis Versus Pre-Emptive Therapy for Cytomegalovirus after Hematopoietic Stem-Cell Transplantation

Giulia Gabrielli, Danilo Giuseppe Giuseppe Faraci, Aurora Martin, Giuseppe Lia, Sara Butera, Irene Dogliotti, Cerrano Marco, Giovannino Ciccone, Simone Ferrero, Anna Castiglione, Elisa Zanotto, Rossana Cavallo, Chiara Maria Dellacasa, Alessandro Busca, Benedetto Bruno, Luisa Giaccone

Blood (2021) 138 (Supplement 1): 4861.

https://doi.org/10.1182/blood-2021-148409

Published: 2021

Journal Articles

COVID-19 Infection in Vaccinated Adult Patients with Hematological Malignancies. Preliminary Results from Epicovideha (Epidemiology of COVID-19 infection in patients with hematological malignancies: A European Haematology Association Survey)

Francesco Marchesi, Jon Salmanton-García, Alberto Lopez-Garcia, Giulia Dragonetti, Uluhan Sili, Andreas Glenthoej, Caterina Buquicchio, Malgorzata Mikulska, Barbora Weinbergerova, Alessandro Busca, Paolo Corradini, Martin Hoenigl, Nikolay N. Klimko, Antonio Pagliuca, Francesco Passamonti, Philipp Köhler, Oliver Cornely, Livio Pagano

Blood (2021) 138 (Supplement 1): 3733.

https://doi.org/10.1182/blood-2021-147295

Published: 2021

Journal Articles

Infections in Patients with Lymphoproliferative Diseases Treated with Target Therapy. Italian Multicentric Retrospective Study Seifem 2017

Gianpaolo Nadali, MD, Gessica Marchesini, MD, Davide Facchinelli, MD, Francesca Farina, MD, Maria Chiara Tisi, MD, Federica Lessi, MD, Francesco Marchesi, Chiara Cattaneo, MD, Anna Candoni, MD, Rosa Fanci, Lucia Prezioso, MD, Luisa Verga, MD, Luca Laurenti, MD, Fabio Trastulli, MD, Marco Picardi, MD, Maria Ilaria Del Principe, MD, Ronaldo Silva, PhD, Alessandro Busca

Blood (2018) 132 (Supplement 1): 4164.

https://doi.org/10.1182/blood-2018-99-111518

Published: 2018

Journal Articles

Isavuconazole in Hematological Patients: Results of a Real-Life Multicenter Seifem Study

Blood (2018) 132 (Supplement 1): 3710.

https://doi.org/10.1182/blood-2018-99-113772

Published: 2018

Journal Articles

Assesment of Frailty Scores Validating Fitness of Elderly AML Patients for Intensive Chemotherapy: A Single Centre Study

Semra Aydin, MD PhD, Marco Franzino, MD, Chiara Frairia, MD, Ernesta Audisio, MD, Stefano D'Ardia, MD, Irene Urbino, MD, Alessandro Busca, MD, Chiara Maria Dellacasa, MD, Giorgia Iovino, MD, Andrea Evangelista, Giovannino Ciccone, MD PhD, Umberto Vitolo

Blood (2018) 132 (Supplement 1): 5171.

https://doi.org/10.1182/blood-2018-99-116836

Published: 2018

Journal Articles

Incidence of HLA Loss in a Global Multicentric Cohort of Post-Transplantation Relapses: Results from the Hlaloss Collaborative Study

Luca Vago, MD PhD, Cristina Toffalori, Müberra Ahci, Vinzenz Lange, PhD, Kathrin Lang, Sonia Todaro, Francesca Lorentino, Karin Stempelmann, Andreas Heinold, Friedrich Stoelzel, Miguel Waterhouse, Rainer Claus, Ketevan Gendzekhadze, Masahiro Onozawa, Raynier Devillier, Ruoping Tang, Maayan Ulman, Mi Kwon, Ivana Gojo, MD, Loredana Ruggeri, Annalisa Imovilli, Luca Facchini, Dejan Lazarevic, Maria Teresa Lupo Stanghellini, Jacopo Peccatori, Nina Kristin Steckel, Peter A. Horn, Alessandra Picardi, Sara Manetta, Alessandro Busca, Jose Luis Pinana, Jaime Sanz, Carolina Martínez-Laperche, Stefan O. Ciurea, Leo Luznik, MD, Andrea Velardi, William Arcese, Guillermo Sanz, Massimo Pini, Benedetto Bruno, Guido Kobbe, Monzr Al Malki, MD, Takanori Teshima, Nicolaus Kroeger, Jürgen Finke, MD, Arnon Nagler, MD, Didier Blaise, Mohamad Mohty, MD PhD, Martin Bornhäuser, Dietrich W. Beelen, Alexander H. Schmidt, Fabio Ciceri, MD, Katharina Fleischhauer

Blood (2018) 132 (Supplement 1): 818.

https://doi.org/10.1182/blood-2018-99-112142

Published: 2018

Journal Articles

Reduced Relapse and Improved Survival in Chemosensitive Hodgkin Lymphoma Patients Undergoing Haploidentical Related Donor Compared to HLA-Identical Donor Transplantation

Blood (2017) 130 (Supplement 1): 3309.

https://doi.org/10.1182/blood.V130.Suppl_1.3309.3309

Published: 2017

Journal Articles

Sequential High-Dose Chemotherapy Reinduction Followed By Haploidentical Transplantation in Acute Leukemias

Lucia Brunello, Roberto Passera, Chiara Maria Dellacasa, Luisa Giaccone, Ernesta Audisio, Dario Ferrero, Stefano D'Ardia, Bernardino Allione, Semra Aydin, Moreno Festuccia, Elena Crisà, Enrico Maffini, Sara Butera, Mario Boccadoro, Umberto Vitolo, MD, Alessandro Busca, Benedetto Bruno

Blood (2017) 130 (Supplement 1): 4588.

https://doi.org/10.1182/blood.V130.Suppl_1.4588.4588

Published: 2017

NARROW

Pharmacogenetics and Pharmacokinetics of Posaconazole in Patients with Acute Myeloid Leukemia: Useful Tools for Antifungal Stewardship

Impact of COVID-19 in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax: A Possible Role of the Association to Anti-CD20 Antibody? a Multicentre Seifem Study

Prognostic Factors Impacting Post-Transplant Outcomes in Adult T-Cell Acute Lymphoblastic Leukemia: A Registry-Based Study By the EBMT Acute Leukemia Working Party

Chronic Obstructive Pulmonary Disease and Previous Infections Have Impact on Infectious Complications in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax: A Multicentre Seifem Study

Score to Guide Donor Choice in Haploidentical Stem Cell Transplant Using Post-Transplant Cyclophosphamide for Patients with Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the EBMT

Gimema Seifem Real-Life Study VS Randomized CPX-351 Registrative Trial for Older Patients with Secondary ACUTE Myeloid Leukemia: An Unanchored Matching-Adjusted Indirect Comparison of Infection Rates and Survival Outcomes

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

Long-Term Analysis of an Open-Label, Multicentre, Randomized Phase 3 Trial Comparing Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine As a Preparative Regimen for Allogeneic Stem-Cell Transplantation in Patients with Acute Myeloid Leukemia

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

Comparative Study of Treosulfan Plus Fludarabine (FT14) with Busulfan Plus Fludarabine (FB4) for Acute Myeloid Leukemia in First or Second Complete Remission: An Analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)

Significance of Degree of HLA Disparity When Using Haploidentical Donors with T-Replete PBSC and Post-Transplantation Cyclophosphamide (PTCy) in Acute Myeloid Leukemia (AML) in First Complete Hematologic Remission (CR1)

Posaconazole at Standard Dose Is Safe and More Effective Than Echinocandins As IFD Prophylaxis in Patients with FLT3 Mutated AML Treated with Midostaurin

Letermovir Prophylaxis Versus Pre-Emptive Therapy for Cytomegalovirus after Hematopoietic Stem-Cell Transplantation

COVID-19 Infection in Vaccinated Adult Patients with Hematological Malignancies. Preliminary Results from Epicovideha (Epidemiology of COVID-19 infection in patients with hematological malignancies: A European Haematology Association Survey)

Infections in Patients with Lymphoproliferative Diseases Treated with Target Therapy. Italian Multicentric Retrospective Study Seifem 2017

Isavuconazole in Hematological Patients: Results of a Real-Life Multicenter Seifem Study

Assesment of Frailty Scores Validating Fitness of Elderly AML Patients for Intensive Chemotherapy: A Single Centre Study

Incidence of HLA Loss in a Global Multicentric Cohort of Post-Transplantation Relapses: Results from the Hlaloss Collaborative Study

Reduced Relapse and Improved Survival in Chemosensitive Hodgkin Lymphoma Patients Undergoing Haploidentical Related Donor Compared to HLA-Identical Donor Transplantation

Sequential High-Dose Chemotherapy Reinduction Followed By Haploidentical Transplantation in Acute Leukemias

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only